PFIZER EUROPE MA EEIG
ItalyAll drugs from this manufacturer
-
It is an anticancer medicine used to treat adults with a type of non-small cell lung cancer (NSCLC) with specific genetic characteristics (ALK or ROS1). It is also indicated for children and adolescents with anaplastic large cell lymphoma (ALCL) or inflammatory myofibroblastic tumor (IMT) with ALK gene defects.
Dosage form: capsules, hard gelatin
Active substance Dosage crizotinib - ATC: L01ED01
-
This medicine is used for the treatment of several inflammatory diseases, including rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, and juvenile psoriatic arthritis.
Dosage form: tablets, film-coated
Active substance Dosage tofacitinib - ATC: L04AF01
-
It is used for the treatment of several types of cancer in adults, including colorectal cancer (colon or rectum), breast cancer, non-small cell lung cancer, kidney cancer, ovarian cancer (including Fallopian tubes and primary peritoneum), and cervical cancer.
Dosage form: solution for infusion, concentrate
Active substance Dosage bevacizumab - ATC: L01FG01
-
It is used to prevent bone complications (such as fractures) in adults with bone metastases, to reduce high calcium levels in the blood caused by cancer, and for the treatment of Paget's disease of the bone in adults.
Dosage form: solution for infusion, concentrate
Active substance Dosage zoledronic acid monohydrate - ATC: M05BA08